New Coalition Launches to End Cannabis Prohibition, Bridge Across Ideological, Party Lines

New Coalition Launches to End Cannabis Prohibition, Bridge Across Ideological, Party LinesBuckeye Relief | buckeyerelief.comThe Buckeye Relief infused-foods team, including Kitchen Manager Emily Rollo (front left), Executive Chef Marc London (front right), Kitchen Tech Lupe Rivera (back row, from left), Kitchen Tech Ricardo Yepez and Assistant Kitchen Manager Ryan Fatica, carefully craft a line of cannabis edibles with a focus on taste and effectiveness.The first time Marc London received a complaint about the taste of his chocolate, there was only one response he deemed appropriate. “Thank you,” said London, the executive chef at Buckeye Relief, a medical cannabis cultivator and processor in Eastlake, Ohio, about 15 miles northeast of Cleveland, where he and Kitchen Manager Emily Rollo carefully craft infused

Khiron Becomes First Colombian Medical Cannabis Company to Export Live Cannabis Clones to Europe

Khiron Becomes First Colombian Medical Cannabis Company to Export Live Cannabis Clones to Europe Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce that the Company has successfully exported its registered Colombian cannabis strains, in the form of live clones, to Europe. This significant milestone represents the first shipment of medical cannabis live plant material to Europe from Colombia and is expected to accelerate access to European markets as the Company executes on its asset light growth strategy in the United Kingdom and Germany. Through its EU-GMP certified supply chain partners in Europe, Khiron plans to introduce branded, cannabis-based medicinal

The Aphria-Tilray Mega Merger: 7 Key Takeaways From ISS and Glass Lewis

The Aphria-Tilray Mega Merger: 7 Key Takeaways From ISS and Glass Lewis Earlier today, Aphria Inc. (TSX: APHA) (Nasdaq: APHA) received a positive nod from Institutional Shareholder Services Inc. (ISS) and Glass Lewis as it relates to the proposed mega-merger with Tilray, Inc. (Nasdaq: TLRY). Since initially learning about the business combination, we have been bullish on the combined company due to the assets that are owed by each operator. From Canada to the European Union, Aphria and Tilray own strategic domestic and international cannabis assets. Going forward, we are bullish on the growth profile of the combined company and find the risk-reward to be favorable for both operators. ISS and Glass Lewis are leading independent proxy advisory firms that provide voting recommendations

$MSOS Will Need Some Serious Tailwinds To Outpace $MJ Going Into Q2 2021

$MSOS Will Need Some Serious Tailwinds To Outpace $MJ Going Into Q2 2021 During the last month, we have noticed a major divergence as it relates to performance of US multi-state operators (MSOs) and the Canadian Licensed Producers (LPs). This is a trend that caught our attention as Canadian LPs have outperformed US MSOs during the last month.  When comparing the performance of  ETFMG Alternative Harvest ETF (MJ) and AdvisorShares Pure US Cannabis ETF (MSOS) in March, the gap between the two indices has widened and we believe our readers need to be aware of this trend. The MJ ETF is composed of Canadian LPs while MSOS is composed of US cannabis companies and we like to use these indices as a

Jushi Holdings Announces Update on Expansion Project at Pennsylvania Grower-Processor Facility

Jushi Holdings Announces Update on Expansion Project at Pennsylvania Grower-Processor FacilityThe SAFE Banking Act is back in Congress, and political momentum is swinging in favor of the cannabis industry’s need to normalize its relations with financial institutions.Safe Harbor Services’ credit union banked $3 billion in cannabis funds last year, part of a vast but fairly under-the-radar ecosystem where businesses are building rapport with smaller independent financial institutions like regional credit unions. There’s a lot to know to make sure that it’s a productive relationship, and federal reform is only one piece of the puzzle. Much of the work falls to the cannabis business, of course.Here, we spoke with Safe Harbor Services Vice President Amanda McComb about some of the recent

Email Drip Series #3 – Moskowitz Report Full

Email Drip Series #3 - Moskowitz Report FullEmerging biotechs are researching once forbidden drugs to solve some of the most vexing medical problems...those of mental health.Major investors have launched this sector with over a half-billion dollars in start-up capitalization and they’re already seeing substantial returns!This trend is just getting started!Forbes reports that the emerging market in new psychoactive mental health medications... “could bring in a whopping $6.85 billion by 2027.”1We are Now Entering Phase Two of a Pharmaceutical RenaissanceResearch is mounting. An entirely new class of psychoactive medications is showing profound efficacy in treating mental disorders and traumatic brain injuries.This is cutting edge medical science that has been buried for decades by out-of-date taboos. But times are changing.Findings are that once-forbidden psycho-active